ATLASArcus Biosciences (RCUS) earnings date: Nov 4, 2026
Arcus Biosciences (RCUS) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$0.92.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RCUS
| Last price | $18.19 (-2.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Arcus Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Arcus Biosciences reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Arcus Biosciences. You can switch it off at any time.
Alert me before RCUS reportsFree to start. Creating an account takes under a minute.
RCUS earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.92 |
| Last report | Oct 27, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +22.3% |
| Average move around a report | ±3.5% (last 4) |
| Sector | Healthcare · Biotechnology |
Arcus Biosciences earnings history: last 4 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | -$0.92 | – | +100.0% | Beat | +3.6% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | -5.2% |
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | +4.9% |
| May 5, 2026 | -$0.83 | -$1.02 | -22.9% | Miss | -0.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RCUS
See the fair value, the probability range and the earnings history of Arcus Biosciences on its ATLAS page.
Arcus Biosciences (RCUS) stock analysisPlans from €3.99 a month.
Arcus Biosciences earnings: frequently asked questions
When does Arcus Biosciences (RCUS) report earnings?
Arcus Biosciences is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RCUS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.92 per share (USD). Estimates can change before the report.
How often does RCUS beat earnings estimates?
Of its last 4 reports with a recorded result, Arcus Biosciences beat the EPS estimate 3 times; the average surprise was +22.3%. Past results do not predict the next one.
How much does RCUS move around earnings?
Over its last 4 reports the stock moved an average of 3.5% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
How much does RCUS usually move in a day?
On a normal trading day the ATLAS model puts RCUS’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer